Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard Versus Double Alpha Blockers Treatment for Symptomatic Benign Prostatic Obstruction: A Randomized Clinical Trial

NCT07815379 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT07815379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07815379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard Versus Double Alpha Blockers Treatment for Symptomatic Benign Prostatic Obstruction: A Randomized Clinical Trial
Lead sponsor
Mansoura University
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 12, 2025
Completion date
November 30, 2026
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bph (benign prostatic hyperplasia)